Trial Profile
RNOP-09: Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma - a Phase II Study.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 May 2019
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Therapeutic Use
- 29 Jul 2009 New trial record